The role of genetic counselling in managing inherited disorders in neonates

الملخص

The existence of inherited disorders among newborns creates substantial difficulties for perinatal healthcare organisations, leading to increased mortality rates and negative developmental outcomes, in addition to elevated morbidity. According to researchers, genetic counselling represents an essential interdisciplinary approach that enhances diagnostic processes and supports decision-making by working with families experiencing such conditions (Resta et al., 2006; Skirton and Patch, 2013). The management of inherited disorders in newborn infants through genetic counselling necessitates evaluation from various perspectives, including clinical administration, ethical considerations, and psychosocial challenges (Biesecker and Peters, 2001).Through a rigorous review of contemporary literature and clinical guidelines, this study delineates the responsibilities of genetic counsellors in risk assessment, interpretation of genomic data, emotional support, and interdisciplinary collaboration (Skirton and Patch, 2013). The research examines how genetic counselling contributes to early identification, presents various intervention strategies, and facilitates long-term family planning efforts (Ormond, 2013). Legal and ethical aspects are thoroughly analysed, with a focus on the informed consent process, cultural sensitivity, and the potential for genetic-based discrimination (Middleton, Morley and Parker, 2014). The article also addresses persistent challenges such as a shortage of trained professionals, inconsistency in practice standards, and complexities in genome interpretation (Abacan et al., 2019). Finally, it explores two emerging trends in the field: the integration of artificial intelligence in counselling tools and the expansion of genomic screening applications (Topol, 2019). This article advocates for the implementation of comprehensive genetic counselling services within standard neonatal care protocols, as these enhance clinical outcomes and support families in navigating complex genetic scenarios.

المراجع

1. Abacan, M. et al. (2019) ‘The global state of the genetic counseling profession’, European Journal of Human Genetics, 27(2), pp. 183–197. https://doi.org/10.1038/s41431-018-0252-x
2. American Society of Human Genetics (ASHG) (1975) ‘Genetic counseling: Report of the Subcommittee on Genetic Counseling’, American Journal of Human Genetics, 27(2), pp. 240–242.
3. Anderson, R.L. et al. (2021) ‘Genomic medicine and its implications for neonatal intensive care units’, Journal of Neonatal Medicine, 46(3), pp. 244–253. https://doi.org/10.1002/jnm.3055
4. Arksey, H. and O'Malley, L. (2005) ‘Scoping studies: Towards a methodological framework’, International Journal of Social Research Methodology, 8(1), pp. 19–32. https://doi.org/10.1080/1364557032000119616
5. Barker, A. and Long, R. (2017) ‘Ethical frameworks in genetic counseling for neonatal conditions: A comparative analysis of international practices’, Ethics, Medicine and Public Health, 3(2), pp. 278–287. https://doi.org/10.1016/j.jemep.2017.01.005
6. Berg, J.S. et al. (2011) ‘The potential for next-generation sequencing in the diagnosis and management of inherited genetic disorders’, American Journal of Human Genetics, 88(5), pp. 557–566. https://doi.org/10.1016/j.ajhg.2011.04.003
7. Biesecker, B.B. and Peters, K.F. (2001) ‘Process studies in genetic counseling: Peering into the black box’, American Journal of Medical Genetics, 106(3), pp. 191–198. https://doi.org/10.1002/ajmg.10006
8. Bondy, C.A. (2007) ‘Turner syndrome 2008’, Hormone Research, 68(5), pp. 231–237. https://doi.org/10.1159/000154088
9. Buchbinder, M. and Danziger, L. (2021) ‘Legal, ethical, and social issues in genetic counseling: A review’, Journal of Medical Ethics, 47(2), pp. 125–132. https://doi.org/10.1136/medethics-2020-106001
10. Bull, M.J. (2020) ‘Down syndrome’, New England Journal of Medicine, 382(24), pp. 2344–2352. https://doi.org/10.1056/NEJMra1706537
11. Chinnery, P.F. and Hudson, G. (2013) ‘Mitochondrial genetics’, British Medical Bulletin, 106(1), pp. 135–159. https://doi.org/10.1093/bmb/ldt017
12. Cowan, M.L. and DeVries, C.A. (2022) ‘Navigating genetic information in neonates: Perspectives from parents and healthcare providers’, European Journal of Human Genetics, 30(7), pp. 1098–1107. https://doi.org/10.1038/s41431-022-01084-0
13. Cutting, G.R. (2015) ‘Cystic fibrosis genetics: From molecular understanding to clinical application’, Nature Reviews Genetics, 16(1), pp. 45–56. https://doi.org/10.1038/nrg3849
14. Greer, J.P. et al. (2020) ‘The role of genetic counseling in the management of inherited blood disorders in newborns’, Hematology/Oncology Clinics of North America, 34(1), pp. 131–143. https://doi.org/10.1016/j.hoc.2019.09.008
15. Guthrie, R. and McGrath, S. (2015) ‘The impact of genetic counseling on decision-making for prenatal and neonatal screening’, American Journal of Obstetrics and Gynecology, 213(4), pp. 456.e1–456.e10. https://doi.org/10.1016/j.ajog.2015.04.013
16. Haigh, S. et al. (2017) ‘Psychosocial considerations in genetic counseling for inherited neonatal disorders’, Journal of Genetic Counseling, 26(2), pp. 298–306. https://doi.org/10.1007/s10897-016-0052-x
17. Kessler, S. (1997) ‘Psychological aspects of genetic counseling. XI. Nondirectiveness revisited’, American Journal of Medical Genetics, 72(2), pp. 164–171. https://doi.org/10.1002/(SICI)1096-8628(19971003)72:2<164::AID-AJMG17>3.0.CO;2-V
18. Kohler, M. et al. (2018) ‘Genomic counseling for rare genetic disorders in neonates: Challenges and opportunities’, Molecular Genetics & Genomic Medicine, 6(3), pp. 573–582. https://doi.org/10.1002/mgg3.381
19. Krause, R. and O’Connor, K. (2019) ‘Neonatal genetic disorders and the role of family-centered genetic counseling’, Pediatrics, 144(3), e20182647. https://doi.org/10.1542/peds.2018-2647
20. Lee, C.S. et al. (2020) ‘The psychological effects of genetic counseling in neonates with rare genetic conditions’, Psychology and Health, 35(12), pp. 1497–1508. https://doi.org/10.1080/08870446.2020.1813182
21. Levac, D., Colquhoun, H. and O'Brien, K.K. (2010) ‘Scoping studies: Advancing the methodology’, Implementation Science, 5(1), p. 69. https://doi.org/10.1186/1748-5908-5-69
22. Middleton, A., Morley, K.I. and Parker, M. (2014) ‘Consent and the use of health records for research: A review’, Journal of Medical Ethics, 40(6), pp. 365–370. https://doi.org/10.1136/medethics-2012-101548
23. Moher, D. et al. (2009) ‘Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement’, PLOS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097
24. Ormond, K.E. (2013) ‘From genetic counselling to “genomic counselling”’, Molecular Genetics & Genomic Medicine, 1(4), pp. 189–193. https://doi.org/10.1002/mgg3.43
25. Page, M.J. et al. (2021) ‘The PRISMA 2020 statement: An updated guideline for reporting systematic reviews’, BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
26. Pierpont, M.E. et al. (2018) ‘Genetic basis for congenital heart disease: Revisited: A scientific statement from the American Heart Association’, Circulation, 138(21), pp. e653–e711. https://doi.org/10.1161/CIR.0000000000000606
27. Piel, F.B. et al. (2017) ‘Sickle cell disease’, New England Journal of Medicine, 376(16), pp. 1561–1573. https://doi.org/10.1056/NEJMra1510865
28. Resta, R.G. et al. (2006) ‘A new definition of genetic counselling: National Society of Genetic Counselors’ task force report’, Journal of Genetic Counseling, 15(2), pp. 77–83. https://doi.org/10.1007/s10897-005-9014-3
29. Rudolf, R. et al. (2019) ‘Neonatal screening for inherited metabolic disorders: Ethical implications and psychological impact on parents’, Journal of Genetic Counseling, 28(4), pp. 1237–1245. https://doi.org/10.1007/s10897-019-00375-1
30. Schmidt, J.T. et al. (2018) ‘Genetic counseling as a tool for improving early diagnosis and care for neonates with inherited disorders’, Genetic Medicine, 20(5), pp. 517–524. https://doi.org/10.1038/s41436-017-0044-z
31. Skirton, H. and Patch, C. (2013) ‘Genetic education and the challenge of genomic medicine: Development of core competences to support preparation of health professionals in Europe’, European Journal of Human Genetics, 21(9), pp. 994–998. https://doi.org/10.1038/ejhg.2012.283
32. Topol, E. (2019) ‘High-performance medicine: The convergence of human and artificial intelligence’, Nature Medicine, 25(1), pp. 44–56. https://doi.org/10.1038/s41591-018-0300-7
33. Vijayakumar, S. and Saha, S. (2020) ‘Genetic counseling and the evolving role of genomic medicine in neonatal care’, Journal of Pediatrics and Neonatology, 62(5), pp. 543–549. https://doi.org/10.1016/j.jpeds.2020.04.001
34. Wang, D.L. et al. (2019) ‘Genetic counseling and the role of artificial intelligence in neonatal care: A review’, Nature Medicine, 25(6), pp. 832–841. https://doi.org/10.1038/s41591-019-0464-6